Guan, Kun-Liang
University of California San Diego · Moores Cancer Center
62 papers on CoChatORCID 0000-0003-1892-0174
Most cited papers
- Verified
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery
Hippo pathway signaling and YAP/TAZTGF-β signaling in diseases
Cited by 860
- Verified
Differential regulation of mTORC1 by leucine and glutamine
Jewell, J. L., Kim, Y. C., Russell, R. C., Yu, F.-X., Park, H. W., Plouffe, S. W., Tagliabracci, V. S., & Guan, K.-L. (2015) · Science
PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy
Cited by 757
- Verified
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
Alexander, A., Cai, S.-L., Kim, J., Nanez, A., Sahin, M., MacLean, K. H., Inoki, K., Guan, K.-L., Shen, J., Person, M. D., et al. (2010) · Proceedings of the National Academy of Sciences
PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy
Cited by 717
- Verified
TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.-L., Liu, Y., & Zheng, P. (2008) · The Journal of Experimental Medicine
Hematopoietic Stem Cell TransplantationPI3K/AKT/mTOR signaling in cancer
Cited by 682
- Verified
A gp130–Src–YAP module links inflammation to epithelial regeneration
Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature
Cytokine Signaling Pathways and InteractionsHippo pathway signaling and YAP/TAZ
Cited by 633
- Verified
The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR
Egan, D., Kim, J., Shaw, R. J., & Guan, K.-L. (2011) · Autophagy
Autophagy in Disease and TherapyPI3K/AKT/mTOR signaling in cancer
Cited by 627
- Verified
Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS
Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K., Zhao, S., & Xiong, Y. (2011) · The EMBO Reports
Sirtuins and Resveratrol in MedicineRedox biology and oxidative stress
Cited by 572
- Verified
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L. (2015) · Nature Cell Biology
Hippo pathway signaling and YAP/TAZMetabolism, Diabetes, and Cancer
Cited by 557
- Verified
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 538
- Verified
The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase
Liu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., et al. (2010) · Journal of Biological Chemistry
Hippo pathway signaling and YAP/TAZUbiquitin and proteasome pathways
Cited by 525
- Verified
Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis
Wang, K.-C., Yeh, Y.-T., Nguyen, P., Limqueco, E., Lopez, J., Thorossian, S., Guan, K.-L., Li, Y.-S. J., & Chien, S. (2016) · Proceedings of the National Academy of Sciences
Hippo pathway signaling and YAP/TAZAtherosclerosis and Cardiovascular Diseases
Cited by 471
- Verified
YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012) · Nature Cell Biology
Hippo pathway signaling and YAP/TAZPI3K/AKT/mTOR signaling in cancer
Cited by 453
- Verified
Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction
Hallows, W. C., Yu, W., Smith, B. C., Devires, M. K., Ellinger, J. J., Someya, S., Shortreed, M. R., Prolla, T., Markley, J. L., Smith, L. M., et al. (2011) · Molecular Cell
Sirtuins and Resveratrol in MedicineAutophagy in Disease and Therapy
Cited by 389
- Verified
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell
Cancer, Lipids, and MetabolismLipid metabolism and biosynthesis
Cited by 384
- Verified
RAP2 mediates mechanoresponses of the Hippo pathway
Meng, Z., Qiu, Y., Lin, K. C., Kumar, A., Placone, J. K., Fang, C., Wang, K.-C., Lu, S., Pan, M., Hong, A. W., et al. (2018) · Nature
Hippo pathway signaling and YAP/TAZCellular Mechanics and Interactions
Cited by 377
- Verified
Sestrins inhibit mTORC1 kinase activation through the GATOR complex
Parmigiani, A., Nourbakhsh, A., Ding, B., Wang, W., Kim, Y. C., Akopiants, K., Guan, K.-L., Karin, M., & Budanov, A. V. (2014) · Cell Reports
PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy
Cited by 336
- Verified
Characterization of Hippo Pathway Components by Gene Inactivation
Plouffe, S. W., Meng, Z., Lin, K. C., Lin, B., Hong, A. W., Chun, J. V., & Guan, K.-L. (2016) · Molecular Cell
Hippo pathway signaling and YAP/TAZMicrotubule and mitosis dynamics
Cited by 275
- Verified
A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells
Diao, Y., Fang, R., Li, B., Meng, Z., Yu, J., Qiu, Y., Lin, K. C., Huang, H., Liu, T., Marina, R. J., et al. (2017) · Nature Methods
Genomics and Chromatin DynamicsCRISPR and Genetic Engineering
Cited by 259
- Verified
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2 -deficient Mesothelioma
Tang, T. T., Konradi, A. W., Feng, Y., Peng, X., Ma, M., Li, J., Yu, F.-X., Guan, K.-L., & Post, L. (2021) · Molecular Cancer Therapeutics
Hippo pathway signaling and YAP/TAZSignaling Pathways in Disease
Cited by 245
- Verified
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Ye, D., Guan, K.-L., & Xiong, Y. (2018) · Trends in Cancer
Cancer, Hypoxia, and MetabolismBiochemical Acid Research Studies
Cited by 242
- Verified
The Stress-inducted Proteins RTP801 and RTP801L Are Negative Regulators of the Mammalian Target of Rapamycin Pathway
Corradetti, M. N., Inoki, K., & Guan, K.-L. (2005) · Journal of Biological Chemistry
PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and Cancer
Cited by 237
- Verified
TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase
Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., & Guan, K.-L. (2006) · Journal of Biological Chemistry
Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancer
Cited by 234
- Verified
Estrogen regulates Hippo signaling via GPER in breast cancer
Zhou, X., Wang, S., Wang, Z., Feng, X., Liu, P., Lv, X.-B., Li, F., Yu, F.-X., Sun, Y., Yuan, H., et al. (2015) · Journal of Clinical Investigation
Hippo pathway signaling and YAP/TAZEstrogen and related hormone effects
Cited by 232
- Verified
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer
Hippo pathway signaling and YAP/TAZCancer-related molecular mechanisms research
Cited by 213
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free